Carmen Belmonte

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation.

Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation.

Journal: Advances in therapy

Published: March 31, 2021

Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers.

Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers.

Journal: Basic & clinical pharmacology & toxicology

Published: July 19, 2019

Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention.

Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention.

Journal: Clinical therapeutics

Published: March 12, 2019

Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics.

Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics.

Journal: Journal of psychopharmacology (Oxford, England)

Published: February 22, 2019

CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention.

CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention.

Journal: Clinical pharmacology and therapeutics

Published: October 26, 2018

Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers.

Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers.

Journal: The pharmacogenomics journal

Published: October 17, 2018

Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects.

Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects.

Journal: Journal of psychopharmacology (Oxford, England)

Published: September 26, 2018

Influence of thiopurine S-methyltransferase polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers.

Influence of thiopurine S-methyltransferase polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers.

Journal: Basic & clinical pharmacology & toxicology

Published: August 17, 2018

Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.

Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.

Journal: Basic & clinical pharmacology & toxicology

Published: July 16, 2018

Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants.

Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants.

Journal: Basic & clinical pharmacology & toxicology

Published: February 19, 2018

Influence of CYP2C19 Phenotype on the Effect of Clopidogrel in Patients Undergoing a Percutaneous Neurointervention Procedure.

Influence of CYP2C19 Phenotype on the Effect of Clopidogrel in Patients Undergoing a Percutaneous Neurointervention Procedure.

Journal: Clinical pharmacology and therapeutics

Published: December 22, 2017

Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.

Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.

Journal: Pharmacogenomics

Published: December 02, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026